Pedro Ávila-Ribeiro

GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis

Elsa Vieira‐Sousa, Pedro Augusto Alves, Ana Maria Rodrigues et al. · Annals of the Rheumatic Diseases · 2020 · 61 citations · Full text

Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration

Ulf Lindström, Daniela Di Giuseppe, Bénédicte Delcoigne et al. · Annals of the Rheumatic Diseases · 2021 · 53 citations · Full text

Effect of Comedication With Conventional Synthetic Disease‐Modifying Antirheumatic Drugs on Retention of Tumor Necrosis Factor Inhibitors in Patients With Spondyloarthritis: A Prospective Cohort Study

Alexandre Sepriano, Sofía Ramiro, Désirée van der Heijde et al. · Arthritis & Rheumatology · 2016 · 31 citations

Real-world Longterm Effectiveness of Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis Patients from the Rheumatic Diseases Portuguese Register

Elsa Vieira‐Sousa, Mónica Eusébio, Pedro Ávila-Ribeiro et al. · The Journal of Rheumatology · 2019 · 24 citations

Predictors of response to TNF blockers in patients with polyarticular psoriatic arthritis.

P. Carvalho, Cátia Duarte, Elsa Vieira‐Sousa et al. · PubMed · 2018 · 11 citations

Immunology, Dermatology, Psoriatic Arthritis +18